Skip to search formSkip to main contentSkip to account menu

Eszopiclone

Known as: (S)-Zopiclone, (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate, Esopiclone 
A nonbenzodiazepine, cyclopyrrolone and active stereoisomer of zopiclone with hypnotic and sedative activity and without significant anxiolytic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Products containing the sedative/hypnotic zolpidem were subject to Drug Safety Communications (DSCs) in January and May 2013… 
2017
2017
Upper airway collapsibility predicts the response to several non‐continuous positive airway pressure (CPAP) interventions for… 
Review
2012
Review
2012
BackgroundThe primary objective of this study was to evaluate long-term (24-week) safety of eszopiclone in elderly and nonelderly… 
2011
2011
The prevalence of moderate-to-severe sleep problems is significantly higher among people with multiple sclerosis (MS) than in the… 
2009
2009
Clinical research has shown that co-administration of eszopiclone, a sedative-hypnotic sleeping agent, and fluoxetine, a… 
2008
2008
STUDY OBJECTIVE The present study was designed to compare and contrast the effects of eszopiclone and zolpidem on the states of… 
Review
2008
Review
2008
Given the well-established problems with sleep at high altitude, it is not uncommon for people planning trips to the mountains to… 
Review
2007
Review
2007
OBJECTIVE From a safety perspective, several issues require assessment when a decision is made to prescribe a sleep medication… 
Review
2006
Review
2006
Eszopiclone, a single-isomer, non-benzodiazepine hypnotic agent, is approved for use in the US for the treatment of insomnia for… 
Review
2001
Review
2001
(S)-Zopiclone, a cyclopyrrolone sharing activity with benzodiazepines in the CNS, is a short-acting sedative being developed by…